Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1080/21623945.2021.1965315

http://scihub22266oqcxt.onion/10.1080/21623945.2021.1965315
suck pdf from google scholar
34402717!8381800!34402717
unlimited free pdf from europmc34402717    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid34402717      Adipocyte 2021 ; 10 (1): 408-411
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Resveratrol supplementation reduces ACE2 expression in human adipose tissue #MMPMID34402717
  • de Ligt M; Hesselink MKC; Jorgensen J; Hoebers N; Blaak EE; Goossens GH
  • Adipocyte 2021[Dec]; 10 (1): 408-411 PMID34402717show ga
  • Angiotensin converting enzyme-2 (ACE2) is the cell-surface receptor enabling cellular entry of SARS-CoV-2. ACE2 is highly expressed in adipose tissue (AT), rendering AT a potential SARS-CoV-2 reservoir contributing to massive viral spread in COVID-19 patients with obesity. Although rodent and cell studies suggest that the polyphenol resveratrol alters ACE2, human studies are lacking. Here, we investigated the effects of 30-days resveratrol supplementation on RAS components in AT and skeletal muscle in men with obesity in a placebo-controlled cross-over study. Resveratrol markedly decreased ACE2 (~40%) and leptin (~30%), but did neither alter angiotensinogen, ACE and AT1R expression in AT nor skeletal muscle RAS components. These findings demonstrate that resveratrol supplementation reduces ACE2 in AT, which might dampen SARS-CoV-2 spread in COVID-19.
  • |Adipose Tissue/cytology/*metabolism[MESH]
  • |Angiotensin-Converting Enzyme 2/genetics/*metabolism[MESH]
  • |COVID-19/pathology/virology[MESH]
  • |Cross-Over Studies[MESH]
  • |Dietary Supplements[MESH]
  • |Double-Blind Method[MESH]
  • |Down-Regulation/drug effects[MESH]
  • |Humans[MESH]
  • |Leptin/genetics/metabolism[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Obesity/drug therapy/pathology[MESH]
  • |Placebo Effect[MESH]
  • |Receptor, Angiotensin, Type 1/genetics/metabolism[MESH]
  • |Resveratrol/*administration & dosage/pharmacology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box